Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.7400
0.06078.94%
At close: Dec 15, 4:00 PM EST
$0.6852
-0.0548-7.41%
After Hours: Dec 12, 6:50 PM EST
Comments
Loading...
Barinthus Biotherapeutics (BRNS) Stock Price, Quote, News & History
BRNSNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Barinthus Biotherapeutics (BRNS) stock?
You can purchase shares of Barinthus Biotherapeutics (NASDAQ:BRNS) through any online brokerage.
Who are Barinthus Biotherapeutics (BRNS) competitors?
Other companies in Barinthus Biotherapeutics’s space includes: Serina Therapeutics Inc (AMEX:SER), Intensity Therapeutics Inc (NASDAQ:INTS), Lunai Bioworks Inc (NASDAQ:LNAI), FibroGen Inc (NASDAQ:FGEN) and CollPlant Biotechnologies Ltd (NASDAQ:CLGN).
What is the forecast, or price target, for Barinthus Biotherapeutics (BRNS) stock?
Barinthus Biotherapeutics has a consensus price target of $5.50.
What is the current price for Barinthus Biotherapeutics (BRNS)?
The stock price for Barinthus Biotherapeutics (NASDAQ: BRNS) is $0.6852 last updated December 12, 2025 at 6:50 PM EST.
Does Barinthus Biotherapeutics (BRNS) pay a dividend?
There are no upcoming dividends for Barinthus Biotherapeutics.
When is Barinthus Biotherapeutics (NASDAQ:BRNS) reporting earnings?
Barinthus Biotherapeutics does not have any upcoming earnings scheduled.
Is Barinthus Biotherapeutics (BRNS) going to split?
There is no upcoming split for Barinthus Biotherapeutics.
What sector and industry does Barinthus Biotherapeutics (BRNS) operate in?
Barinthus Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
